Prolonged delirium after quetiapine overdose

Pediatric Emergency Care

Volumn 26, Issue 10, 2010, Pages 754-756

  Rhyee, Sean Hyun ^a   Pedapati, Ernest Vijay ^b   Thompson, Jennifer ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

adolescent; anticholingeric delirium; overdose; physostigmine; poisoning; quetiapine

Indexed keywords

CAFFEINE; CLONIDINE; PHYSOSTIGMINE; QUETIAPINE; RISPERIDONE; TRAZODONE;

ADOLESCENT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; DRUG BLOOD LEVEL; DRUG INTOXICATION; EMERGENCY MEDICINE; FEMALE; HUMAN; LABORATORY TEST; SEDATION; VITAL SIGN;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHOLINERGIC ANTAGONISTS; CLONIDINE; CYTOCHROME P-450 CYP3A; DELIRIUM; DEPRESSION; DIBENZOTHIAZEPINES; DRUG INTERACTIONS; EMERGENCIES; FEMALE; HEART BLOCK; HUMANS; HYPOTENSION; PHYSOSTIGMINE; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED; TACHYCARDIA; TIME FACTORS; TRAZODONE;

EID: 77958577133     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/PEC.0b013e3181f39d5b     Document Type: Article

References (18)

1. Seroquel (quetiapine fumarate). AstraZeneca Pharmaceuticals LP Web site. Available at: http://www1.astrazeneca-us.com/pi/Seroquel.pdf. Accessed March 5, 2009.
2. Burns MJ. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol. 2001;39:1Y14.
3. Antia SX, Sholevar EH, Baron DA. Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol. 2005;15:970Y985.
4. McConville B, Carrero L, Sweitzer D, et al. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol. 2003;13:75Y82.
5. Catalano G, Catalano MC, Agustines RE, et al. Pediatric quetiapine overdose: a case report and literature review. J Child Adolesc Psychopharmacol. 2002;12:355Y361.
6. Remschmidt H, Hennighausen K, Clement HW, et al. Atypical neuroleptics in child and adolescent psychiatry. Eur Child Adolesc Psychiatry. 2000;9:I/9YI/19.
7. Balit CR, Isbister GK, Hackett LP, et al. Quetiapine poisoning: a case series. Ann Emerg Med. 2003;42:751Y758.
8. Young AC, Kleinschmidt KC, Wax PM. Late-onset seizures associated with quetiapine poisoning. J Med Toxicol. 2009;5:24Y26.
9. Baselt RC. Quetiapine. In: Disposition of Toxic Drugs and Chemicals in Man. 7th ed. Foster City, CA: Biomedical Publications; 2004:975Y976.
10. Hunfeld NGM, Westerman EM, Boswijk DJ, et al. Quetiapine in overdosage: a clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit. 2006;28:185Y189.
11. Flammia DD, Valouch T, Venuti S. Tissue distribution of quetiapine in 20 cases in Virginia. J Anal Toxicol. 2006;30:287Y292.
12. Langman LJ, Kaliciak HA, Carlyle S. Fatal overdoses associated with quetiapine. J Anal Toxicol. 2004;28:520Y525.
13. Isbister GK, Friberg LE, Hacket LP, et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther. 2007;81:821Y827.
14. Pollak PT, Zbuk K. Quetiapine fumarate overdose: clinical and pharmacokinetic lessons from extreme conditions. Clin Pharmacol Ther. 2000;68:92Y97.
15. Rotzinger S, Bourin M, Akimoto Y, et al. Metabolism of some Bsecond[- and Bfourth[- generation antidepressants: iprindole, viloxazine, bupropion, mianserin, maprotiline, trazodone, nefazodone, and venlafaxine. Cell Mol Neurobiol. 1999;19:427Y442.
16. Baselt RC. Physostigmine. In: Disposition of Toxic Drugs and Chemicals in Man. 7th ed. Forest City, CA: Biomedical Publications; 2004:908Y909.
17. Beaver KM, Gavin TJ. Treatment of acute anticholinergic poisoning with physostigmine. Am J Emerg Med. 1998;16:505Y507.
18. Zito JM, Safer DJ, dosReis S, et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003;157:17Y25.